Direct-To-Consumer Genetic Testing

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

Product Management & the FDA. Agenda/Scope What is different about managing products in a regulated industry? – Devices; Biologics; Pharma; Consumer goods;
What matters to me Cancer survivorship: A consumer and carers lens on cancer survivorship and its impact on service delivery Toni Ashmore and Dr David.
What is personal genetics? What might it mean for me, my family and society? Personal Genetics Education Project (pgEd) Harvard Medical School
Does knowing personal genomic information change behavior? Nate Cira Gene 210 6/5/2012.
1 Evidence and the next stage of health care reform: Why consumer engagement is so important Steven D. Pearson, MD, MSc President, Institute for Clinical.
Carisa Sanborn and Nikita Meshwani. PATIENTS  People who want to learn about their birth defects  Women who want to know if their children will have.
Personalized Medicine The Promise of the Genomic Revolution.
My project: 23andMe.com : Emerging genetic testing services from online websites23andMe.com 23andMe.com services offered genetic testing for certain diseases.
Personalized Medicine Dr. M. Jawad Hassan. Personalized Medicine Human Genome and SNPs What is personalized medicine? Pharmacogenetics Case study – warfarin.
D4FF55A0-6B6F BF422A9BA9 Present by: Xiao Chen On December 7, 2015.
What is your section about ?  Clinical psychology is an integration of science, theory and clinical knowledge for the purpose of understanding, preventing,
Personal DNA Testing Melanie Wark Mackenzie Steen.
Direct-to-Consumer Genetic Testing: Outputs from the EASAC-FEAM Working Group Martina Cornel VU University Medical Center, Amsterdam.
Next generation genomics: translation into clinically useful applications in health care Prof.dr. Martina Cornel
LCA1 Erman Ayday, Jean Louis Raisaro and Jean-Pierre Hubaux Privacy-Enhancing Technologies for Medical Tests and Personalized Medicine Laboratory for Computer.
The Patient Experience With Systemic Lupus Erythematosus
Introduction to Direct-to-Consumer Genetic Testing
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Familial Chylomicronemia Syndrome
Timely Diagnosis of Gastroenteritis: Implications for Patients and Public Health.
Assessing COPD in Primary Care
Systemic Lupus Erythematosus
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Major Depressive Disorder: Getting the Patient Back to Work
Starting Strong: Initial Evaluation of the Patient With HCV
HIV Testing:.
Program Goals Overview of HIV Epidemic HIV and Communities of Color.
Progression After Cancer Immunotherapy in Advanced NSCLC
Optimizing Quality of Life and Mental Health in Patients With Psoriasis.
When Minutes Count.
Updates in Management of Atopic Dermatitis From Real Patient Cases
Is Your Patient Engaged in Care
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Managing RA: Telepartnership Between PCP and Rheumatologist
Chronic Idiopathic Urticaria
Screening and Diagnosing Postpartum Depression
HBV Care Models: Community Collaborations for Best Practices
Counseling Patients About Germline BRCA Mutations
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Multidisciplinary Perspectives on Interstitial Lung Diseases
Martina Cornel VU University Medical Center, Amsterdam
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Hyperhidrosis Is Burdensome!
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
A Roadmap to Diagnosing the Next Patient With Hereditary Angioedema
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Program Goals Overview Is NEDA a Reasonable Target?
PAH-Related Morbidity as a Predictor of Mortality
Scientific Update.
Patient-Centered Management in BRAF-Positive Metastatic Melanoma
Expert Perspectives on NIPT
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Are We Making Progress in the Management of Huntington Disease?
Optimizing Joint Health in Hemophilia
Advanced Parkinson Disease: Are We Breaking New Ground?
Improving Overall Health
Peanut Allergy Immunotherapy
Gadolinium Update.
Secondary Progressive Multiple Sclerosis: What Do We Know and Where Are We Heading?
Program Goals Overview Is NEDA a Reasonable Target?
A Closer Look.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Using Biomarkers in MS: Initiating With the Right Therapy in Clinical Practice.
Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
Expert Perspectives.
Biosimilars in Immune-Related Diseases
Presentation transcript:

Direct-To-Consumer Genetic Testing

Background

What DTC Genetic Testing Has to Offer

Some Things to Keep in Mind About DTC Testing

Summary of Important Genetic Terms

Single Nucleotide Polymorphisms (SNPs)

SNPs (cont)

DTC Genetic Testing Is a Simple Process

Platforms for Detecting Variants

Scope of DTC Genetic Testing

23andMe Disease-Based DTC Genetic Tests/ FDA-Authorized*

4 Approaches to Understanding DTC Results

Real Diseases, Real Diagnoses

Gateway to Genomic Medicine

Evolving Field of DTC

Proceed With Caution in the Case of Third-Party Analyses

Patient Story Walt*

Patient Story Walt and DTC Genetic Testing Results

Walt’s Advice to Clinicians

PCP Perspective

Impact of Personal Genomics Study (PGEN)*

PGEN Results Cancer*

PGEN Results Health Behaviors

Scripps Study Psychological, Behavioral, and Clinical Effects of Risk

Scripps Study Psychological, Behavioral, and Clinical Effects of Risk (cont)

PCP and Patient Perspectives in Different Settings or Geographic Areas

Genetic Counselor Perspective

PCP Communication Tips

Role Playing—Common Situations With Patients Prepregnancy Planning

Role Playing—Common Situations With Patients Cancer

Role Playing—Common Situations With Patients An Uncommon Disorder

Concluding Remarks Common Genetic Screens

Concluding Remarks Data

Concluding Remarks Patient Engagement and Education

Concluding Remarks You Don’t Have to Be a Genetic Expert

Abbreviations